JPWO2022271765A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022271765A5 JPWO2022271765A5 JP2023579156A JP2023579156A JPWO2022271765A5 JP WO2022271765 A5 JPWO2022271765 A5 JP WO2022271765A5 JP 2023579156 A JP2023579156 A JP 2023579156A JP 2023579156 A JP2023579156 A JP 2023579156A JP WO2022271765 A5 JPWO2022271765 A5 JP WO2022271765A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- weight
- total weight
- extragranular
- intragranular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163214099P | 2021-06-23 | 2021-06-23 | |
| US63/214,099 | 2021-06-23 | ||
| PCT/US2022/034433 WO2022271765A1 (en) | 2021-06-23 | 2022-06-22 | Pharmaceutical compositions of an epidermal growth factor receptor inhibitor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024525206A JP2024525206A (ja) | 2024-07-10 |
| JPWO2022271765A5 true JPWO2022271765A5 (enrdf_load_stackoverflow) | 2025-06-30 |
Family
ID=82608194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023579156A Pending JP2024525206A (ja) | 2021-06-23 | 2022-06-22 | 上皮成長因子受容体阻害剤の医薬組成物 |
Country Status (9)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116554150A (zh) * | 2022-12-30 | 2023-08-08 | 苏州浦合医药科技有限公司 | 第四代egfr抑制剂 |
| WO2024249660A1 (en) * | 2023-05-31 | 2024-12-05 | Amgen Inc. | Compositions comprising sotorasib |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015152433A1 (en) * | 2014-03-31 | 2015-10-08 | Hanmi Pharm. Co., Ltd. | Amorphous solid dispersion comprising paclitaxel, tablet comprising the same, and method for preparing the same |
| CA3036053A1 (en) * | 2016-09-07 | 2018-03-15 | Celgene Corporation | Tablet compositions |
-
2022
- 2022-06-22 CN CN202280056648.3A patent/CN117835970A/zh active Pending
- 2022-06-22 US US18/573,229 patent/US20240293323A1/en active Pending
- 2022-06-22 WO PCT/US2022/034433 patent/WO2022271765A1/en not_active Application Discontinuation
- 2022-06-22 TW TW111123289A patent/TW202317120A/zh unknown
- 2022-06-22 CA CA3223889A patent/CA3223889A1/en active Pending
- 2022-06-22 IL IL309447A patent/IL309447A/en unknown
- 2022-06-22 AR ARP220101626A patent/AR126195A1/es unknown
- 2022-06-22 EP EP22744033.6A patent/EP4358942A1/en active Pending
- 2022-06-22 JP JP2023579156A patent/JP2024525206A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4999466B2 (ja) | 塩基性薬物又はその塩を含有するマトリックス型徐放性製剤およびその製造方法 | |
| JP5794650B2 (ja) | 難溶性薬物の溶解性改善製剤 | |
| JP5289338B2 (ja) | 医薬固形製剤及びその製造方法 | |
| WO2008027600A2 (en) | Imatinib compositions | |
| EP2844245A1 (en) | New formulation | |
| WO2023195955A1 (en) | A film coated tablet comprising selexi̇pag and its preparation process | |
| WO2023195957A1 (en) | A film coated tablet comprising selexi̇pag processed with wet granulation | |
| KR101331723B1 (ko) | Ｈｃｖ 중합효소 억제제 전구약물을 포함하는 약학 조성물 | |
| US11576917B2 (en) | Pharmaceutical compositions comprising Ibrutinib | |
| WO2020225738A1 (en) | Pharmaceutical composition comprising venetoclax | |
| JP2016512845A (ja) | ソバプレビル錠剤 | |
| AU2016231883A1 (en) | Pharmaceutical compositions of dimethyl fumarate | |
| EP2685966A1 (en) | Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor | |
| WO2010120963A1 (en) | Tablet formulation for p38 inhibitor and method | |
| CN116036079A (zh) | 一种复合物的药物组合物及其制备方法 | |
| JPWO2022271765A5 (enrdf_load_stackoverflow) | ||
| WO2022153330A1 (en) | Pharmaceutical compositions comprising acalabrutinib | |
| WO2017037645A1 (en) | Stable pharmaceutical formulations of teriflunomide | |
| JP7233852B2 (ja) | 変色が抑制された固形製剤 | |
| WO2022162687A1 (en) | Pharmaceutical compositions comprising nilotinib | |
| WO2019011393A1 (en) | EXTENDED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING FESOTERODINE AND PREPARATION METHOD THEREOF | |
| WO2023048684A2 (en) | The tablet comprising macitentan | |
| WO2023195954A1 (en) | A film coated tablet comprising a solid dispersion of selexi̇pag | |
| WO2022243886A1 (en) | Pharmaceutical composition of ivosidenib | |
| WO2023195956A1 (en) | A film coated tablet comprising selexi̇pag and at least one filler |